Safety and Effectiveness of Lower Alteplase Dose Driven by Impending Clinical Deterioration Factors in very Elderly Submassive Pulmonary Embolism Patients. Case Series. acmcr. 2022;6(5):669-678. Accessed September 11, 2026. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22671